The UK Health Security Agency (UKHSA) has provided a significant update on the meningitis outbreak in Kent. According to UKHSA, there have been no new cases of meningitis reported in the last 24 hours. However, investigations into the meningococcal disease outbreak in Kent are ongoing.
As of 12:30 pm on March 22, there have been 20 confirmed laboratory cases and 9 cases under investigation, totaling 29 cases. This follows the tragic deaths of two individuals earlier this month, which were linked to an outbreak associated with the Club Chemistry nightclub in Canterbury.
Dr. Sherine Thomas, an Infectious Diseases Consultant at UKHSA, emphasized the agency’s continued vigilance in monitoring for new cases and collaborating with NHS England and local authorities nationwide. She expressed gratitude for the response from eligible young individuals seeking antibiotics and vaccination.
While the overall risk to the general population remains low, it is crucial for people to be aware of the symptoms of invasive meningococcal disease and seek immediate medical attention if symptoms arise. UKHSA is actively working with partners to identify contacts and provide necessary treatment.
The number of suspected cases under investigation has decreased from 11 to nine, resulting in a total of 29 cases, down from 34 previously. Nineteen of the confirmed cases are attributed to meningitis B, all of which have required hospitalization.
A suspected case has been linked to another academic institution in Kent, in addition to the University of Kent. The East Kent Colleges (EKC) Group informed parents and carers about a college student being treated for a suspected case of meningitis, with updates published on the institution’s website.
Despite a decline in the number of people queuing for the menB vaccine or antibiotics, efforts to combat the outbreak continue. The UKHSA anticipates further reductions in case numbers as additional laboratory assessments are completed in the coming days.
Tragically, the two individuals who have passed away include 18-year-old Juliette, described as previously healthy by her family. Juliette showed initial symptoms of vomiting and cheek discoloration before her condition rapidly deteriorated. Despite medical intervention, she succumbed to meningitis within hours.
Vinny Smith, the chief executive of Meningitis Research Foundation, highlighted past advocacy for routine menB vaccination for at-risk age groups, emphasizing the need for continued efforts to prevent such tragedies.
This website uses cookies and other identifiers to enhance user experience, analyze site usage, and display personalized advertising. Users can opt out of data sharing by clicking the appropriate button. By using this website, users agree to the use of cookies as outlined in the Privacy Notice and Terms and Conditions.
